3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Prostatic Neoplasms
47
Breast Neoplasms
34
Breast Neoplasms, Male
3
Neoplasms
2
Neoplasm Metastasis
2
Infertility
2
Advanced Breast Cancer
2
Sexual Dysfunction, Physiological
1
Recurrence
1
Prostate Adenocarcinoma
1
Primary Ovarian Insufficiency
1
Osteoporosis
1
Osteitis Deformans
1
Leiomyoma
1
Hot Flashes
1
Hemorrhage
1
Breast Cancer Invasive
1
Anemia
1
Advanced Prostate Cancer
1
Advanced Metastatic Breast Cancer
1
Interventions
ribociclib
1
Tamoxifen
1
Letrozole
1
Goserelin
1
Anastrozole
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Advanced Metastatic Breast Cancer
×
Goserelin
×
Clear all
NCT02278120
2024-03-12
MONALEESA-7
Novartis
Phase 3
Completed
672 enrolled
16 charts
1 FDA